Tue, Sep 16, 2014, 7:30 AM EDT - U.S. Markets open in 2 hrs.

Recent

% | $
Quotes you view appear here for quick access.

Santarus, Inc. (SNTS) Message Board

ktstock786 2 posts  |  Last Activity: Jul 30, 2014 9:29 PM Member since: Jan 24, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Only serious holders

    by ktstock786 Jul 30, 2014 8:17 PM
    ktstock786 ktstock786 Jul 30, 2014 9:29 PM Flag

    Thanks for the information! If they do indeed submit for December this would mean a class 1 resubmission? And it's q1 2015 that means the review only takes 3 months? Thanks I'm advance

  • ktstock786 by ktstock786 Jul 30, 2014 8:17 PM Flag

    Hi All, was just curious to see if anybody has some input or actual research to determine what people feel is the process from now going into the next FDA approval date. How long are we looking it? Do you feel this is a class 1 or class 2 resubmission? Does anybody expect a whole year for PDUFA date as a few articles have suggested or do you feel they are being conservative? What do you expect from the next meeting with the FDA within the 30 days? Any thoughts on how this affects ACRX with their competitors? Sorry if this has been asked before but boards are being spammed.

SNTS
31.960.00(0.00%)Dec 31 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avanir Pharmaceuticals, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
21Vianet Group, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT